CVE-2026-24217

HIGH EPSS 50.8%
Published May 20, 20261mo ago · Modified Jun 17, 20261w ago
8.8 CVSS 3.1
High
Find Similar
Published May 20, 2026 1mo ago
Last Modified Jun 17, 2026 1w ago

Description

NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CVSS Details

Base Score
8.8
Exploitability
2.8
Impact
5.9
Vector string
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Attack Vector Network
Attack Complexity Low
Privileges Required None
User Interaction Required
Scope Unchanged
Confidentiality High
Integrity High
Availability High

Threat Intelligence

EPSS Exploit Probability
50.8% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available

Weaknesses 1

CWE-29

Affected Products 2

VendorProductVersionRange
nvidiabionemo_framework* <2026-04-03
linuxlinux_kernel*any

References 3

  • nvd.nist.gov https://nvd.nist.gov/vuln/detail/CVE-2026-24217
    US Government Resource
  • nvidia.custhelp.com https://nvidia.custhelp.com/app/answers/detail/a_id/5831
    Vendor Advisory
  • cve.org https://www.cve.org/CVERecord?id=CVE-2026-24217
    Third Party Advisory

Remediation

No remediation data recorded yet

Check vendor advisories and the NVD entry for patch availability.